International Support Group
Home Hospitals Doctors How It Works Blog FAQs
Get A Quote
HAEMATOLOGY & STEM CELL THERAPY Procedure

Quadruplet Dara-VRd Induction & Autologous BMT

Proteasome inhibitor (Bortezomib), immunomodulator (Lenalidomide), Daratumumab, and autologous BMT.

Multiple myeloma treatment
Multiple myeloma treatment

Clinical Overview & Disease Information

Proteasome inhibitor (Bortezomib), immunomodulator (Lenalidomide), Daratumumab, and autologous BMT.

Signs & Symptoms

Early Symptoms
  • Early hematological signs
  • Mild Bone pain, high calcium, kidney failure, anemia
Common Symptoms
  • Persistent Bone pain, high calcium, kidney failure, anemia
  • Pancytopenia or abnormal blood counts
  • Lymphadenopathy or bleeding tendency
Emergency Symptoms
  • Neutropenic fever > 100.4°F
  • Severe unprovoked internal hemorrhage

Causes & Risk Factors

Primary Causes & Etiology

  • Multiple Myeloma & Plasma Cell Leukemia
  • Clonal hematopoietic stem cell mutation
  • Inherited hemoglobinopathy / coagulation deficit

Who is at Higher Risk?

  • Patients diagnosed with Multiple Myeloma & Plasma Cell Leukemia
  • Patients requiring BMT or targeted hematology protocols

Diagnostic Evaluation & Testing

Diagnostic Test Clinical Purpose / What It Shows
Bone Marrow Aspirate & Flow Cytometry / NGS for Multiple myeloma treatment High-resolution immunophenotyping, cytogenetics, and molecular testing

Comprehensive Treatment Options

Targeted Cellular / Biologic Protocol for Multiple myeloma treatment

Specialized stem cell transplantation or targeted biotherapy protocol.

Key Advantages:
Curative potential or complete disease control
Targeted precision therapy
High-dose stem cell rescue

Multidisciplinary Hematology Protocol for Multiple myeloma treatment

Comprehensive conditioning chemotherapy or chronic factor replacement program.

Recommended For:
High-risk cytogenetic or refractory disease
Complex hematological disorders

Advanced Medical Technologies Available in Partner Hospitals

Autologous & Allogeneic BMT CAR-T Cell Therapy HLA 10-Allele DNA Typing

Possible Complications If Untreated

Graft-Versus-Host Disease (GVHD)
Neutropenic infection
Bleeding risk

Recovery Timeline, Diet & Lifestyle Care

Recovery Timeline

Procedure / Stage Expected Recovery Duration
HEPA Isolation BMT Unit 14 to 21 days
Stem Cell Engraftment 21 to 28 days
Outpatient Recovery & Taper 3 to 6 months

Recommended Post-Treatment Diet

  • Neutropenic clean diet (cooked food only)
  • Sterile bottled water

Essential Lifestyle Changes

  • Wear N95 mask in public during immunosuppression
  • Take medications at exact 12-hour times
When to Contact a Doctor Urgently:
Fever > 100.4°F
Active bleeding or petechiae
Severe rash or diarrhea

Prevention & Long-Term Health

Complete post-transplant re-vaccination program
Genetic counseling

Frequently Asked Questions

What is the primary benefit of Multiple myeloma treatment?

It offers high cure rates or long-term disease control under expert hematology & BMT teams.

Top Recommended Specialists Available

Dr. Gaurav Dixit

Dr. Gaurav Dixit

Head – Haematology Oncology & Bone Marrow Transplant (Unit II)

View Doctor Profile →
Dr. Rahul Naithani

Dr. Rahul Naithani

Chief - Hematology, Oncology & Bone Marrow Transplant

View Doctor Profile →
Dr. Mukesh Patekar

Dr. Mukesh Patekar

Unit Head - Medical Oncology

View Doctor Profile →
Dr. Vineeta Raina

Dr. Vineeta Raina

Sr. Consultant - Pathology & Hematopathology

View Doctor Profile →
Dr. Arun Singh Danewa

Dr. Arun Singh Danewa

Senior Consultant – Pediatric-Haemato-Oncology & Bone Marrow Transplant (Unit II)

View Doctor Profile →

Global Cost Comparison Matrix

Procedure USA (Avg) India (ISG) Turkey (Avg) Thailand (Avg)
Multiple myeloma treatment $180,000 $9,500 $45,000 $50,000

Request Free Clinical Opinion & Cost Estimate

Upload your diagnostic reports or medical summary for a free review by leading specialists within 24-48 hours.

Get Free Treatment Estimate

Commonly Prescribed Medications

  • Tacrolimus 1mg
  • Acyclovir 400mg
  • Fluconazole 200mg

International Patient Guide

Estimated Stay in India:
Bone Marrow Evaluation & HLA Typing 3 - 5 days
BMT / Protocol Inpatient Stay 21 - 30 days
Engraftment Check & Return Flight 45 - 60 days total stay
Documents to Bring:
  • Passport & Visa
  • Bone Marrow Biopsy CDs & Cytogenetics Reports